Skip to main content
OpenTrials

Clinical trial condition

Migraine Disorders

Explore clinical trials studying Migraine Disorders. Study availability and eligibility vary by location and protocol.

1,130 public trials 139 recruiting studies
Refine in advanced search Browse all conditions

Migraine Disorders trial results

Completed

Headstrong Intervention for Pediatric Headache

NCT00269581

Conditions
Brain Diseases, Central Nervous System Diseases, Chronic Headaches, +5 more
Locations
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Children's Mercy Hospital Kansas City Kansas City, Missouri, United States
View Trial Details
Completed

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

NCT00690716

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • Capnia Investigative Site Birmingham, Alabama, United States
  • Capnia Investigative Site Stanford, California, United States
  • Capnia Investigative Site East Hartford, Connecticut, United States
  • Capnia Investigative Site West Palm Beach, Florida, United States
View all 15 locations
View Trial Details
Completed

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

NCT00510419

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • San Francisco Clinical Research Center San Francisco, California, United States
  • New England Center for Headache Stamford, Connecticut, United States
  • Diamond Head Clinic Chicago, Illinois, United States
  • Michigan Head Pain & Neurological Institute Ann Arbor, Michigan, United States
View Trial Details
Completed

An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine

NCT00319137

Conditions
Brain Diseases, Central Nervous System Diseases, Headache Disorders, +4 more
Locations
  • GSK Investigational Site Adelaide, South Australia, Australia
  • GSK Investigational Site Auckland, New Zealand
  • GSK Investigational Site Christchurch, New Zealand
  • GSK Investigational Site Hamilton, New Zealand
View Trial Details

Related conditions